Better survival with fludarabine and timed sequential busulfan regimen in older patients with AML/MDS.

Uday R Popat,Rima M Saliba,Betul Oran,Sairah Ahmed,Amin Majid Alousi,Qaiser Bashir,Stefan O. Ciurea,Chitra Hosing,Partow Kebriaei,Issa F Khouri,David Marin,Yago Nieto,Amanda Olson,Muzaffar H. Qazilbash,Katayoun Rezvani,Ben C. Valdez,Roy B. Jones,Elizabeth J. Shpall,Borje S Andersson,Richard E Champlin

Better survival with fludarabine and timed sequential busulfan regimen in older patients with AML/MDS.

2017

7046Background: We previously reported 6% 100 day NRM with a MA fludarabine (Flu) and busulfan (Bu) in older patients with a median age of 60 years. MA dose of Bu in this timed sequential (TS) regi...

Keywords:

Regimen
Busulfan
Physical therapy
Fludarabine
Medicine
Oncology
Internal medicine
older patients

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations